Why Parkinson’s Cognitive Trials May Use More Than One Thinking Test
See which thinking and daily-life tests Parkinson’s trials use and how to get clearer test results.
Parkinson’s Dementia Research and the Need for Everyday Function Measures
See why daily-task ability defines Parkinson’s dementia and how to track changes for care decisions.
Parkinson’s Research Headlines: Why a Promising Early Trial May Not Lead to Approval
Learn how to read Parkinson’s trial headlines, spot early-stage limits, and ask sharper questions at your next visit.
Parkinson’s Trial Placebo Groups: What Care Do Participants Still Receive?
Learn what medicines, checkups and exit rights stay in place on placebo so you can join a trial with confidence.
Parkinson’s Clinical Trials: How to Tell Symptom Relief From Slower Disease Progression
See how trial design, OFF-drug scores and biomarkers separate lasting slowing from daily symptom ease.
Parkinson’s Biomarker Studies: Does Detecting a Protein Explain What Caused the Disease?
Learn what a positive synuclein test means for diagnosis, treatment talks, and trial options.
Parkinson’s Environmental Research: Why Exposure Timing May Matter as Much as Amount
Learn which life stages raise Parkinson’s risk most and what exposure history to share with your doctor.
Genes and Pesticides in Parkinson’s Research: Can Both Contribute to Risk?
See how specific genes and farm pesticides interact in Parkinson’s and steps to lower exposure risk.
Parkinson’s Protein Redistribution Diet: Purpose and Cautions
Learn how shifting protein to dinner may steady levodopa response and what safeguards to discuss with your care team.
Caregiver Burnout in Parkinson’s: Warning Signs and Respite Options
Spot early burnout signs and find scheduled breaks, local respite, and daily habits that protect Parkinson’s caregivers.